The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLERGAN PLC | SHS | G0177J108 | 4,186 | 25,000 | SH | SOLE | 22,308 | 2,692 | 0 | ||
| ALTISOURCE ASSET MGMT CORP | COM | 02153X108 | 795 | 69,122 | SH | SOLE | 69,122 | 0 | 0 | ||
| ANADARKO PETE CORP | COM | 032511107 | 63,426 | 898,900 | SH | SOLE | 856,900 | 42,000 | 0 | ||
| ARRAY BIOPHARMA INC | COM | 04269X105 | 695 | 15,000 | SH | SOLE | 13,118 | 1,882 | 0 | ||
| CELGENE CORP | COM | 151020104 | 29,832 | 322,721 | SH | SOLE | 312,581 | 10,140 | 0 | ||
| CVS HEALTH CORP | COM | 126650100 | 7,378 | 135,400 | SH | Call | SOLE | 134,700 | 700 | 0 | |
| CVS HEALTH CORP | COM | 126650100 | 12,114 | 222,309 | SH | SOLE | 212,389 | 9,920 | 0 | ||
| GENESEE & WYO INC | CL A | 371559105 | 1,500 | 15,000 | SH | SOLE | 13,385 | 1,615 | 0 | ||
| MELLANOX TECHNOLOGIES LTD | SHS | M51363113 | 19,232 | 173,776 | SH | SOLE | 151,596 | 22,180 | 0 | ||
| RED HAT INC | COM | 756577102 | 83,962 | 447,175 | SH | SOLE | 431,297 | 15,878 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 32,828 | 320,653 | SH | SOLE | 291,853 | 28,800 | 0 | ||
| ZAYO GROUP HLDGS INC | COM | 98919V105 | 20,488 | 622,559 | SH | SOLE | 592,665 | 29,894 | 0 | ||